Shares of Abbott Laboratories have moved -0.2% today, and are now trading at a price of $135.78. In contrast, the S&P 500 index saw a -0.0% change. Today's trading volume is 424,677 compared to the stock's average volume of 6,407,979.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Based in North Chicago, United States the company has 114,000 full time employees and a market cap of $236,319,522,816. Abbott Laboratories currently offers its equity investors a dividend that yields 1.7% per year.
The company is now trading -4.87% away from its average analyst target price of $142.72 per share. The 25 analysts following the stock have set target prices ranging from $122.0 to $159.0, and on average give Abbott Laboratories a rating of buy.
Over the last 52 weeks, ABT stock has risen 18.5%, which amounts to a 2.0% difference compared to the S&P 500. The stock's 52 week high is $141.23 whereas its 52 week low is $110.86 per share. Based on Abbott Laboratories's average net margin growth of 17.7% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 41,950,000 | 13,402,000 | 32 | 128.57 |
| 2023 | 40,109,000 | 5,723,000 | 14 | -12.5 |
| 2022 | 43,653,000 | 6,933,000 | 16 | 0.0 |
| 2021 | 43,075,000 | 7,071,000 | 16 | 23.08 |
| 2020 | 34,608,000 | 4,495,000 | 13 | 8.33 |
| 2019 | 31,904,000 | 3,687,000 | 12 |
